Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
11,420,830
-
Shares change
-
+4,092,395
-
Total reported value, excl. options
-
$341,203,000
-
Value change
-
+$123,064,104
-
Number of buys
-
26
-
Number of sells
-
-11
-
Price
-
$29.87
Significant Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q1 2021
43 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") as of Q1 2021.
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,420,830 shares
of 22,866,677 outstanding shares and own 49.95% of the company stock.
Largest 10 shareholders include TYBOURNE CAPITAL MANAGEMENT (HK) LTD (1,957,961 shares), SV Health Investors, LLC (1,915,274 shares), JANUS HENDERSON GROUP PLC (1,693,658 shares), Point72 Asset Management, L.P. (1,577,493 shares), Logos Global Management LP (800,000 shares), Atlas Venture Advisors, Inc. (612,696 shares), FIL Ltd (523,201 shares), SAMLYN CAPITAL, LLC (437,728 shares), EVENTIDE ASSET MANAGEMENT, LLC (411,838 shares), and Verition Fund Management LLC (240,134 shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.